Small Intestinal Bacterial Overgrowth in Children with Short Bowel Syndrome

Area of Science:

• Pediatric Gastroenterology
• Microbiology
• Surgical Gastroenterology

Background:

• Short Bowel Syndrome (SBS) in children often leads to Small Intestinal Bacterial Overgrowth (SIBO) due to anatomical and functional changes.
• SIBO in SBS can cause significant gastrointestinal issues, nutritional deficiencies, and severe complications like D-lactic acidosis.

Purpose of the Study:

• To review the characteristics, diagnostic challenges, and management strategies for SIBO in pediatric SBS patients.
• To highlight the need for improved diagnostic tools and integrated care approaches.

Main Methods:

• Literature review of SIBO in pediatric SBS, focusing on pathophysiology, clinical presentation, diagnosis, and treatment.
• Analysis of current diagnostic methods (breath testing, jejunal aspiration) and their limitations in SBS.
• Evaluation of established and emerging therapeutic interventions, including antibiotics and novel agents.

Main Results:

• SIBO is a common complication in pediatric SBS, manifesting with diverse gastrointestinal symptoms and malabsorption.
• Current diagnostic methods for SIBO in SBS patients have significant limitations in accuracy and practicality.
• Antibiotics (e.g., rifaximin) are primary treatments, but recurrence is frequent, necessitating comprehensive management strategies.

Conclusions:

• Managing SIBO in pediatric SBS requires a multidisciplinary team approach, combining gastroenterological, surgical, and nutritional expertise.
• Further research is crucial for developing more accurate diagnostic tools and refining treatment protocols for SIBO in this vulnerable population.
• Emerging therapies like GLP-2 analogs show potential for improving mucosal health and reducing SIBO recurrence in SBS.